Concepedia

Christopher Allen

CA

9

Publications

401

Citations

9

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Belgium)

Marqués de Valdecilla University Hospital

Christopher Allen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1999–2008

9

Publications

9

Comparison of Rizatriptan 10 Mg vs. Zolmitriptan 2.5 Mg in the Acute Treatment of Migraine

Julio Pascual, HC Diener, Christopher Allen et al. · Cephalalgia · 2000 · 85 citations

, , +16

Coprescription of Triptans With Potentially Interacting Medications: A Cohort Study Involving 240 268 Patients

Stewart J. Tepper, Christopher Allen, David S. Sanders et al. · Headache The Journal of Head and Face Pain · 2003 · 57 citations

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

Michel Farnier, Massimo Volpe, Rachid Massaad et al. · International Journal of Cardiology · 2005 · 51 citations

, , +9

Comparison of Preference for Rizatriptan 10-mg Wafer versus Sumatriptan 50-mg Tablet in Migraine

Julio Pascual, Gennaro Bussone, Jose Fernando Hernandez et al. · European Neurology · 2001 · 46 citations

LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia

C. Brohet, Shmuel Banai, A. Marco Alings et al. · Current Medical Research and Opinion · 2005 · 44 citations

Rows per page

1–5 of 9